Decreased risk of drug toxicity (neutropenia, thrombocytopenia, anemia, mucositis and alopecia) was observed in carriers of CYP2B6 *1/*6 and CYP2B6*6/*6 genotypes (Table 3). The gene discussed is CYP2B6; the disease is neutropenia.